D Josefson. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antitubercular Agents/therapeutic useHumansLegislation, DrugRifampin/analogs & derivativesRifampin/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances: See more » Antitubercular AgentsRifampinrifapentine
Year: 1998 PMID: 9705629 DOI: 10.1136/bmj.317.7150.11a
Source DB: PubMed Journal: BMJ ISSN: 0959-8138